Dexcom Inc. logo

Dexcom Inc. (DXCM)

Market Closed
5 Dec, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
65. 49
+0.24
+0.37%
$
24.46B Market Cap
134.71 P/E Ratio
0% Div Yield
3,644,150 Volume
1.43 Eps
$ 65.25
Previous Close
Day Range
65.15 66.75
Year Range
54.11 93.25
Want to track DXCM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 68 days
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against DexCom, Inc. - DXCM

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against DexCom, Inc. - DXCM

NEW YORK, NY / ACCESSWIRE / October 19, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against DexCom, Inc. ("DexCom" or the "Company") (NASDAQ:DXCM). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

Accesswire | 1 year ago
DXCM DEADLINE UPDATE: DexCom, Inc. Investors are Alerted of Monday, October 21 Court Deadline; Contact BFA Law about Securities Fraud Class Action

DXCM DEADLINE UPDATE: DexCom, Inc. Investors are Alerted of Monday, October 21 Court Deadline; Contact BFA Law about Securities Fraud Class Action

NEW YORK, NY / ACCESSWIRE / October 18, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against DexCom, Inc. (NASDAQ:DXCM) and certain of the Company's senior executives. If you invested in DexCom, you are encouraged to obtain additional information by visiting Click Here

Accesswire | 1 year ago
Faruqi & Faruqi Reminds DexCom Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 21, 2024 - DXCM

Faruqi & Faruqi Reminds DexCom Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 21, 2024 - DXCM

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In DexCom To Contact Him Directly To Discuss Their Options NEW YORK CITY, NY / ACCESSWIRE / October 18, 2024 / If you suffered losses exceeding $100,000 in DexCom between April 28, 2023 to July 25, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against DexCom, Inc. ("DexCom" or the "Company") (NASDAQ:DXCM) and reminds investors of the October 21, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

Accesswire | 1 year ago
Where Will DexCom Be in 5 Years?

Where Will DexCom Be in 5 Years?

Recent developments might have scared away some investors, but patience could pay off.

Fool | 1 year ago
DXCM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit!

DXCM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit!

NEW YORK CITY, NY / ACCESSWIRE / October 18, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against DexCom, Inc. ("DexCom" or "the Company") (NASDAQ:DXCM) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired DexCom securities between April 28, 2023, and July 25, 2024, inclusive (the "Class Period").

Accesswire | 1 year ago
DXCM FRAUD UPDATE: DexCom, Inc. Investors have until Monday, October 21 to Contact BFA Law about the Court Deadline in Securities Fraud Class Action (Nasdaq:DXCM)

DXCM FRAUD UPDATE: DexCom, Inc. Investors have until Monday, October 21 to Contact BFA Law about the Court Deadline in Securities Fraud Class Action (Nasdaq:DXCM)

NEW YORK, NY / ACCESSWIRE / October 17, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against DexCom, Inc. (NASDAQ:DXCM) and certain of the Company's senior executives. If you invested in DexCom, you are encouraged to obtain additional information by visiting Click Here

Accesswire | 1 year ago
Earnings Preview: DexCom (DXCM) Q3 Earnings Expected to Decline

Earnings Preview: DexCom (DXCM) Q3 Earnings Expected to Decline

DexCom (DXCM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 1 year ago
DXCM Deadline in 5 Days: Kessler Topaz Meltzer & Check, LLP Reminds DexCom, Inc. (DXCM) Investors of Filing Deadline in Class Action Lawsuit

DXCM Deadline in 5 Days: Kessler Topaz Meltzer & Check, LLP Reminds DexCom, Inc. (DXCM) Investors of Filing Deadline in Class Action Lawsuit

RADNOR, PA / ACCESSWIRE / October 16, 2024 / The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that securities class action lawsuits have been filed against DexCom, Inc. ("DexCom") (NASDAQ:DXCM) on behalf of investors who purchased or otherwise acquired DexCom securities between April 28, 2023 and July 25, 2024, inclusive (the "Class Period") The lead plaintiff deadline is October 21, 2024. CONTACT KESSLER TOPAZ MELTZER & CHECK, LLP: If you suffered DexCom losses, you may CLICK HERE or go to: Click Here You can also contact attorney Jonathan Naji, Esq.

Accesswire | 1 year ago
INVESTOR DEADLINE TUESDAY: DexCom, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - DXCM

INVESTOR DEADLINE TUESDAY: DexCom, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - DXCM

SAN DIEGO, CA / ACCESSWIRE / October 16, 2024 / Robbins Geller Rudman & Dowd LLP announces that the DexCom class action lawsuit - captioned Alonzo v. DexCom, Inc., No.

Accesswire | 1 year ago
Investors in DexCom, Inc. Should Contact Levi & Korsinsky Before October 21, 2024 to Discuss Your Rights - DXCM

Investors in DexCom, Inc. Should Contact Levi & Korsinsky Before October 21, 2024 to Discuss Your Rights - DXCM

NEW YORK, NY / ACCESSWIRE / October 16, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 1 year ago
DXCM FRAUD ALERT: BFA Law Alerts DexCom, Inc. Investors to Contact the Firm before Upcoming October 21 Court Deadline in Securities Fraud Class Action

DXCM FRAUD ALERT: BFA Law Alerts DexCom, Inc. Investors to Contact the Firm before Upcoming October 21 Court Deadline in Securities Fraud Class Action

NEW YORK, NY / ACCESSWIRE / October 16, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against DexCom, Inc. (NASDAQ:DXCM) and certain of the Company's senior executives. If you invested in DexCom, you are encouraged to obtain additional information by visiting Click Here

Accesswire | 1 year ago
Shareholders that lost money on DexCom, Inc.(DXCM) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More

Shareholders that lost money on DexCom, Inc.(DXCM) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More

NEW YORK, NY / ACCESSWIRE / October 16, 2024 / If you suffered a loss on your DexCom, Inc. (NASDAQ:DXCM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 1 year ago
Loading...
Load More